HHS Adds Rare Diseases to Newborn Tests, Sarepta Rises

Sarepta rises as HHS recommends newborn screening for Duchenne muscular dystrophy and metachromatic leukodystrophy, aiming for earlier diagnosis and treatment.

HHS Adds Rare Diseases to Newborn Tests, Sarepta Rises
Credit: Sarepta Therapeutics
Already have an account? Sign in.